Read news on diabetes patients with our app.
Read more in the app
Rice Biotech Launch Pad hosts foundation representatives, Type 1 diabetes patients and advocates for campus tour - EurekAlert
Long-term sulfonylurea use linked to higher risk of low blood sugar unawareness in type 2 diabetes patients - EurekAlert
New medicine can create a new life for diabetes patients -- without needles!
Nearly 40% of Type 2 diabetes patients stop taking their second-line medication
